In this study we have performed high-resolution copy number, LOH and gene expression profiling of 120 familial breast carcinomas selected from a larger cohort of 155 familial breast tumors, including BRCA1, BRCA2 and CHEK2 mutant tumors. This evidence concerns the gene BRCA1 and breast carcinoma.